Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Ketone esters for treatment of angelman syndrome

Ketone esters for treatment of angelman syndrome

US Patent 9364456 · Granted Jun 14, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for weight loss maintenance2025
Ketone supplements-evoked effect on absence epilepsy by co-administration of uri2024
Metabolic therapy for wound healing2023
Animal model of Angelman Syndrome2023
Exogenous ketone supplements for reducing anxiety-related behavior2023
Drug-induced activation of the Reelin signaling system2023
Compositions and methods for weight loss maintenance2023
Modified UBE3A gene for a gene therapy approach for angelman syndrome2022
Prevention and treatment of muscle wasting with ketone supplementation2022
Drug-induced activation of the Reelin signaling system2022
Exogenous ketone supplements for reducing anxiety-related behavior2021
Delaying latency to seizure by combinations of ketone supplements2021